41
Orient Pharma
4166.TW·TWSETaipei TWFounded 1952800 employees
Micro CappharmaPublicOncologyCardiology
Platform: Generic CNS
Market Cap
$0.2B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (4166.TW)
Loading 4166.TW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 416-6807 | 416-6807 | Phase 2 | 2 | CD3 | RAMDS | ||
| Ivozasiran | 416-3409 | Phase 1/2 | 2 | Tau | ETEpilepsy |
SEC Filings & Financial Documents
SEC filings are not available for TWSE-listed companies.
Orient Pharma trades on TWSE (TW). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)